{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:19:38Z","timestamp":1774383578834,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0950"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0950"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024MD754020"],"award-info":[{"award-number":["2024MD754020"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87130-4","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T01:34:11Z","timestamp":1737509651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrated analysis of genetic, proteinic, and metabolomic alterations in Behcet\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Yanlin","family":"Pu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuiren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongdan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"87130_CR1","doi-asserted-by":"publisher","first-page":"109272","DOI":"10.1016\/j.clim.2023.109272","volume":"249","author":"Y Yazici","year":"2023","unstructured":"Yazici, Y. & Hatemi, G. Difficult-to-treat Behcet syndrome: A therapeutic approach. Clin. Immunol. 249, 109272. https:\/\/doi.org\/10.1016\/j.clim.2023.109272 (2023).","journal-title":"Clin. Immunol."},{"key":"87130_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40168-018-0520-6","volume":"6","author":"Z Ye","year":"2018","unstructured":"Ye, Z. et al. A metagenomic study of the gut microbiome in Behcet\u2019s disease. Microbiome 6, 135. https:\/\/doi.org\/10.1186\/s40168-018-0520-6 (2018).","journal-title":"Microbiome"},{"key":"87130_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","volume":"18","author":"RA Watts","year":"2022","unstructured":"Watts, R. A., Hatemi, G., Burns, J. C. & Mohammad, A. J. Global epidemiology of vasculitis. Nat. Rev. Rheumatol. 18, 22\u201334. https:\/\/doi.org\/10.1038\/s41584-021-00718-8 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"87130_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1080\/09273948.2020.1746352","volume":"29","author":"BL Oh","year":"2021","unstructured":"Oh, B. L., Lee, J. S., Lee, E. Y., Lee, H. Y. & Yu, H. G. Incidence and risk factors for blindness in uveitis: A nationwide cohort study from 2002 to 2013. Ocular Immunol. Inflamm. 29, 1040\u20131044. https:\/\/doi.org\/10.1080\/09273948.2020.1746352 (2021).","journal-title":"Ocular Immunol. Inflamm."},{"key":"87130_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12016-014-8425-z","volume":"49","author":"Y Ozyazgan","year":"2015","unstructured":"Ozyazgan, Y., Ucar, D., Hatemi, G. & Yazici, Y. Ocular involvement of Behcet\u2019s syndrome: A comprehensive review. Clin. Rev. Allergy Immunol. 49, 298\u2013306. https:\/\/doi.org\/10.1007\/s12016-014-8425-z (2015).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"87130_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jaci.2011.07.008","volume":"128","author":"H Direskeneli","year":"2011","unstructured":"Direskeneli, H., Fujita, H. & Akdis, C. A. Regulation of TH17 and regulatory T cells in patients with Behcet disease. J. Allergy Clin. Immunol. 128, 665\u2013666. https:\/\/doi.org\/10.1016\/j.jaci.2011.07.008 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"87130_CR7","doi-asserted-by":"publisher","first-page":"109303","DOI":"10.1016\/j.clim.2023.109303","volume":"250","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y. et al. Interferon-alpha2a induces CD4(+) T cell apoptosis and suppresses Th1\/Th17 responses via upregulating IRF1-mediated PDL1 expression in dendritic cells from Behcet\u2019s uveitis. Clin. Immunol. 250, 109303. https:\/\/doi.org\/10.1016\/j.clim.2023.109303 (2023).","journal-title":"Clin. Immunol."},{"key":"87130_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"M Pineton de Chambrun","year":"2012","unstructured":"Pineton de Chambrun, M., Wechsler, B., Geri, G., Cacoub, P. & Saadoun, D. New insights into the pathogenesis of Behcet\u2019s disease. Autoimmun. Rev. 11, 687\u2013698. https:\/\/doi.org\/10.1016\/j.autrev.2011.11.026 (2012).","journal-title":"Autoimmun. Rev."},{"key":"87130_CR9","doi-asserted-by":"publisher","first-page":"109056","DOI":"10.1016\/j.clim.2022.109056","volume":"240","author":"S Tan","year":"2022","unstructured":"Tan, S. et al. The pro-inflammatory effect of triglyceride on human CD4(+) T cells and experimental autoimmune uveitis. Clin. Immunol. 240, 109056. https:\/\/doi.org\/10.1016\/j.clim.2022.109056 (2022).","journal-title":"Clin. Immunol."},{"key":"87130_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi, G. et al. 2018 update of the EULAR recommendations for the management of Behcet\u2019s syndrome. Ann. Rheumatic Dis. 77, 808\u2013818. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213225 (2018).","journal-title":"Ann. Rheumatic Dis."},{"key":"87130_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41398-022-01947-5","volume":"12","author":"J Pu","year":"2022","unstructured":"Pu, J. et al. Effects of pharmacological treatment on metabolomic alterations in animal models of depression. Transl Psychiatry. 12, 175. https:\/\/doi.org\/10.1038\/s41398-022-01947-5 (2022).","journal-title":"Transl Psychiatry"},{"key":"87130_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.15252\/emmm.201606798","volume":"8","author":"J Goveia","year":"2016","unstructured":"Goveia, J. et al. Meta-analysis of clinical metabolic profiling studies in cancer: Challenges and opportunities. EMBO Mol. Med. 8, 1134\u20131142. https:\/\/doi.org\/10.15252\/emmm.201606798 (2016).","journal-title":"EMBO Mol. Med."},{"key":"87130_CR13","doi-asserted-by":"publisher","first-page":"7328","DOI":"10.1038\/s41380-021-01269-w","volume":"26","author":"J Pu","year":"2021","unstructured":"Pu, J. et al. Metabolomic changes in animal models of depression: A systematic analysis. Mol. Psychiatry. 26, 7328\u20137336. https:\/\/doi.org\/10.1038\/s41380-021-01269-w (2021).","journal-title":"Mol. Psychiatry"},{"key":"87130_CR14","doi-asserted-by":"publisher","first-page":"101226","DOI":"10.1016\/j.smrv.2019.101226","volume":"49","author":"X Janssen","year":"2020","unstructured":"Janssen, X. et al. Associations of screen time, sedentary time and physical activity with sleep in under 5s: A systematic review and meta-analysis. Sleep. Med. Rev. 49, 101226. https:\/\/doi.org\/10.1016\/j.smrv.2019.101226 (2020).","journal-title":"Sleep. Med. Rev."},{"key":"87130_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","volume":"17","author":"A Greco","year":"2018","unstructured":"Greco, A. et al. Behcet\u2019s disease: New insights into pathophysiology, clinical features and treatment options. Autoimmun. Rev. 17, 567\u2013575. https:\/\/doi.org\/10.1016\/j.autrev.2017.12.006 (2018).","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"87130_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3(2), 133\u2013146 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"87130_CR17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1189\/jlb.0105035","volume":"78","author":"P Puddu","year":"2005","unstructured":"Puddu, P. et al. IL-2 induces expression and secretion of IFN-gamma in murine peritoneal macrophages. J. Leukoc. Biol. 78, 686\u2013695. https:\/\/doi.org\/10.1189\/jlb.0105035 (2005).","journal-title":"J. Leukoc. Biol."},{"key":"87130_CR18","doi-asserted-by":"publisher","unstructured":"Yasuda, K., Nakanishi, K. & Tsutsui, H. Interleukin-18 in health and disease. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20030649 (2019).","DOI":"10.3390\/ijms20030649"},{"issue":"2","key":"87130_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/intimm\/12.2.151","volume":"12","author":"K Tominaga","year":"2000","unstructured":"Tominaga, K. et al. IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int. Immunol. 12(2), 151\u2013160 (2000).","journal-title":"Int. Immunol."},{"key":"87130_CR20","doi-asserted-by":"publisher","first-page":"151956","DOI":"10.1016\/j.semarthrit.2022.151956","volume":"52","author":"TB van der Houwen","year":"2022","unstructured":"van der Houwen, T. B., van Hagen, P. M. & van Laar, J. A. M. Immunopathogenesis of Behcet\u2019s disease and treatment modalities. Seminars Arthritis Rheumat. 52, 151956. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.151956 (2022).","journal-title":"Seminars Arthritis Rheumat"},{"key":"87130_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s12016-016-8582-3","volume":"52","author":"CB Chighizola","year":"2017","unstructured":"Chighizola, C. B., Ong, V. H. & Meroni, P. L. The use of cyclosporine a in rheumatology: A 2016 comprehensive review. Clin. Rev. Allergy Immunol. 52, 401\u2013423. https:\/\/doi.org\/10.1007\/s12016-016-8582-3 (2017).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"87130_CR22","doi-asserted-by":"publisher","first-page":"637829","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca, C. et al. Role of the IL-23\/IL-17 pathway in rheumatic diseases: An overview. Front. Immunol. 12, 637829. https:\/\/doi.org\/10.3389\/fimmu.2021.637829 (2021).","journal-title":"Front. Immunol."},{"key":"87130_CR23","doi-asserted-by":"publisher","unstructured":"Meng, F. et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143, 765\u2013776 e763, (2012). https:\/\/doi.org\/10.1053\/j.gastro.2012.05.049","DOI":"10.1053\/j.gastro.2012.05.049"},{"key":"87130_CR24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.autrev.2011.12.005","volume":"11","author":"ZY Zhou","year":"2012","unstructured":"Zhou, Z. Y., Chen, S. L., Shen, N. & Lu, Y. Cytokines and Behcet\u2019s disease. Autoimmun. Rev. 11, 699\u2013704. https:\/\/doi.org\/10.1016\/j.autrev.2011.12.005 (2012).","journal-title":"Autoimmun. Rev."},{"key":"87130_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.autrev.2016.02.012","volume":"15","author":"Y Ferfar","year":"2016","unstructured":"Ferfar, Y. et al. Biotherapies in large vessel vasculitis. Autoimmun. Rev. 15, 544\u2013551. https:\/\/doi.org\/10.1016\/j.autrev.2016.02.012 (2016).","journal-title":"Autoimmun. Rev."},{"key":"87130_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ophtha.2021.11.013","volume":"129","author":"M Leclercq","year":"2022","unstructured":"Leclercq, M. et al. Anti-tumor necrosis factor alpha versus tocilizumab in the treatment of refractory uveitic macular edema: A multicenter study from the French Uveitis network. Ophthalmology 129, 520\u2013529. https:\/\/doi.org\/10.1016\/j.ophtha.2021.11.013 (2022).","journal-title":"Ophthalmology"},{"key":"87130_CR27","doi-asserted-by":"publisher","unstructured":"Gul, A. Standard and novel therapeutic approaches to Behcet\u2019s disease. Drugs 67, 2013\u2013 (2022). https:\/\/doi.org\/10.2165\/00003495-200767140-00004 (2007). Karampetsou, M. P., Liossis, S. N. & Sfikakis, P. P. TNF-alpha antagonists beyond approved indications: Stories of success and prospects for the future. QJM Month. J. Assoc. Phys. 103, 917\u2013928, doi:10.1093\/qjmed\/hcq152 (2010).","DOI":"10.2165\/00003495-200767140-00004"},{"key":"87130_CR28","doi-asserted-by":"publisher","unstructured":"Karampetsou, M. P., Liossis, S. N. & Sfikakis, P. P. TNF-alpha antagonists beyond approved indications: stories of success and prospects for the future. QJM : monthly journal of the Association of Physicians 103, 917-928, https:\/\/doi.org\/10.1093\/qjmed\/hcq152 (2010).","DOI":"10.1093\/qjmed\/hcq152"},{"key":"87130_CR29","doi-asserted-by":"publisher","unstructured":"Javier, R. C. et al. Beh\u00e7et disease: From pathogenesis to novel therapeutic options. Pharmacol. Res. 167 https:\/\/doi.org\/10.1016\/j.phrs.2021.105593 (2021).","DOI":"10.1016\/j.phrs.2021.105593"},{"key":"87130_CR30","doi-asserted-by":"publisher","unstructured":"Pietro, L. et al. Beh\u00e7et\u2019s disease: An overview of Etiopathogenesis. Front. Immunol. 10 https:\/\/doi.org\/10.3389\/fimmu.2019.01067 (2019).","DOI":"10.3389\/fimmu.2019.01067"},{"key":"87130_CR31","doi-asserted-by":"publisher","first-page":"109161","DOI":"10.1016\/j.clim.2022.109161","volume":"245","author":"X Yu","year":"2022","unstructured":"Yu, X. et al. Transcriptional analysis of neutrophils from patients with Behcet\u2019s disease reveals activation and chemotaxis of neutrophils. Clin. Immunol. 245, 109161. https:\/\/doi.org\/10.1016\/j.clim.2022.109161 (2022).","journal-title":"Clin. Immunol."},{"issue":"2","key":"87130_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1365-2567.1998.00506.x","volume":"94","author":"H Nakagawa","year":"1998","unstructured":"Nakagawa, H., Sunada, Y. & Ando, Y. Biological activities of C3 beta c, a novel neutrophil chemoattractant derived from the beta-chain of rat complement C3. Immunology 94(2), 253\u2013257 (1998).","journal-title":"Immunology"},{"issue":"3","key":"87130_CR33","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.4049\/jimmunol.155.3.1428","volume":"155","author":"ME Hammond","year":"1995","unstructured":"Hammond, M. E. et al. CXCL8 induces neutrophil chemotaxis predominantly via type I CXCL8 receptors. J. Immunol. 155(3), 1428\u20131433 (1995).","journal-title":"J. Immunol."},{"issue":"2","key":"87130_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.chom.2008.07.002","volume":"4","author":"AS Zinkernagel","year":"2008","unstructured":"Zinkernagel, A. S. et al. The CXCL8 protease SpyCEP\/ScpC of group a streptococcus promotes resistance to neutrophil killing. Cell. Host Microbe. 4(2), 170\u2013178 (2008).","journal-title":"Cell. Host Microbe"},{"key":"87130_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/19490976.2019.1629235","volume":"11","author":"M Stephens","year":"2020","unstructured":"Stephens, M. & von der Weid, P. Y. Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner. Gut Microbes. 11, 421\u2013432. https:\/\/doi.org\/10.1080\/19490976.2019.1629235 (2020).","journal-title":"Gut Microbes"},{"key":"87130_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2014.08.008","volume":"14","author":"L Cantarini","year":"2015","unstructured":"Cantarini, L. et al. Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behcet\u2019s disease. Autoimmun. Rev. 14, 1\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.008 (2015).","journal-title":"Autoimmun. Rev."},{"key":"87130_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1182\/blood-2018-01-769018","volume":"132","author":"AM Randi","year":"2018","unstructured":"Randi, A. M., Smith, K. E. & von Castaman, G. Willebrand factor regulation of blood vessel formation. Blood 132, 132\u2013140. https:\/\/doi.org\/10.1182\/blood-2018-01-769018 (2018).","journal-title":"Blood"},{"key":"87130_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad, M. & Martin, J. C. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat. Rev. Immunol. 20, 355\u2013362. https:\/\/doi.org\/10.1038\/s41577-020-0331-4 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"87130_CR39","doi-asserted-by":"publisher","unstructured":"Nelemans, T. & Kikkert, M. Viral innate immune evasion and the pathogenesis of emerging RNA virus infections. Viruses 11 https:\/\/doi.org\/10.3390\/v11100961 (2019).","DOI":"10.3390\/v11100961"},{"key":"87130_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jaad.2017.11.064","volume":"79","author":"CA Nelson","year":"2018","unstructured":"Nelson, C. A. et al. Neutrophilic dermatoses: Pathogenesis, sweet syndrome, neutrophilic eccrine hidradenitis, and Behcet disease. J. Am. Acad. Dermatol. 79, 987\u20131006. https:\/\/doi.org\/10.1016\/j.jaad.2017.11.064 (2018).","journal-title":"J. Am. Acad. Dermatol."},{"key":"87130_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0049-3848(02)00006-3","volume":"105","author":"S Kiraz","year":"2002","unstructured":"Kiraz, S. et al. Pathological haemostasis and prothrombotic state in Behcet\u2019s disease. Thromb. Res. 105, 125\u2013133. https:\/\/doi.org\/10.1016\/s0049-3848(02)00006-3 (2002).","journal-title":"Thromb. Res."},{"key":"87130_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara, N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr. Rev. 25, 581\u2013611. https:\/\/doi.org\/10.1210\/er.2003-0027 (2004).","journal-title":"Endocr. Rev."},{"key":"87130_CR43","doi-asserted-by":"publisher","first-page":"100954","DOI":"10.1016\/j.preteyeres.2021.100954","volume":"84","author":"A Uemura","year":"2021","unstructured":"Uemura, A. et al. VEGFR1 signaling in retinal angiogenesis and microinflammation. Progress Retinal Eye Res. 84, 100954. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100954 (2021).","journal-title":"Progress Retinal Eye Res."},{"key":"87130_CR44","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1093\/eurheartj\/ehy529","volume":"39","author":"TJ Ford","year":"2018","unstructured":"Ford, T. J. et al. Systemic microvascular dysfunction in microvascular and vasospastic angina. Eur. Heart J. 39, 4086\u20134097. https:\/\/doi.org\/10.1093\/eurheartj\/ehy529 (2018).","journal-title":"Eur. Heart J."},{"key":"87130_CR45","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","volume":"27","author":"N Mackman","year":"2007","unstructured":"Mackman, N., Tilley, R. E. & Key, N. S. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler. Thromb. Vasc Biol. 27, 1687\u20131693. https:\/\/doi.org\/10.1161\/ATVBAHA.107.141911 (2007).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"87130_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jbspin.2014.06.007","volume":"82","author":"E Capkin","year":"2015","unstructured":"Capkin, E. et al. Ischemia-modified albumin (IMA): A novel marker of vascular involvement in Behcet\u2019s disease? Joint Bone Spine. 82, 68\u201369. https:\/\/doi.org\/10.1016\/j.jbspin.2014.06.007 (2015).","journal-title":"Joint Bone Spine"},{"issue":"3","key":"87130_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12020-009-9236-5","volume":"36","author":"K Ukinc","year":"2009","unstructured":"Ukinc, K. et al. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: Ischemia-modified albumin. Endocrine 36(3), 425\u2013432 (2009).","journal-title":"Endocrine"},{"key":"87130_CR48","doi-asserted-by":"crossref","unstructured":"Talat, L., Lightman, S. & Tomkins-Netzer, O. Ischemic retinal vasculitis and its management. J. Ophthalmol., 2014: p. 197675. (2014).","DOI":"10.1155\/2014\/197675"},{"key":"87130_CR49","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/ATVBAHA.122.317164","volume":"42","author":"AS Wolberg","year":"2022","unstructured":"Wolberg, A. S. & Sang, Y. Fibrinogen and factor XIII in venous thrombosis and thrombus stability. Arterioscler. Thromb. Vasc Biol. 42, 931\u2013941. https:\/\/doi.org\/10.1161\/ATVBAHA.122.317164 (2022).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"87130_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.blre.2019.03.002","volume":"35","author":"B Samuelson Bannow","year":"2019","unstructured":"Samuelson Bannow, B. et al. Long-established role in haemophilia A and emerging evidence beyond haemostasis. Blood Rev. 35, 43\u201350. https:\/\/doi.org\/10.1016\/j.blre.2019.03.002 (2019). Factor VIII.","journal-title":"Blood Rev."},{"key":"87130_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1600-0714.2009.00774.x","volume":"38","author":"A Sun","year":"2009","unstructured":"Sun, A., Wang, Y. P., Chia, J. S., Liu, B. Y. & Chiang, C. P. Treatment with levamisole and colchicine can result in a significant reduction of IL-6, CXCL8 or TNF-alpha level in patients with mucocutaneous type of Behcet\u2019s disease. J. Oral Pathol. Med. Off Publ Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol. 38, 401\u2013405. https:\/\/doi.org\/10.1111\/j.1600-0714.2009.00774.x (2009).","journal-title":"J. Oral Pathol. Med. Off Publ Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol."},{"key":"87130_CR52","doi-asserted-by":"publisher","unstructured":"Zhang, B. et al. Combination of colchicine and Ticagrelor inhibits carrageenan-induced thrombi in mice. Oxidative Med. Cell. Longev. 2022(3087198). https:\/\/doi.org\/10.1155\/2022\/3087198 (2022).","DOI":"10.1155\/2022\/3087198"},{"key":"87130_CR53","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.autrev.2008.04.019","volume":"7","author":"BT Kurien","year":"2008","unstructured":"Kurien, B. T. & Scofield, R. H. Autoimmunity and oxidatively modified autoantigens. Autoimmun. Rev. 7, 567\u2013573. https:\/\/doi.org\/10.1016\/j.autrev.2008.04.019 (2008).","journal-title":"Autoimmun. Rev."},{"key":"87130_CR54","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/CIRCULATIONAHA.115.017738","volume":"133","author":"M Becatti","year":"2016","unstructured":"Becatti, M. et al. Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Behcet disease. Circulation 133, 302\u2013311. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.017738 (2016).","journal-title":"Circulation"},{"key":"87130_CR55","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ejim.2008.08.001","volume":"19","author":"O Harzallah","year":"2008","unstructured":"Harzallah, O., Kerkeni, A., Baati, T. & Mahjoub, S. Oxidative stress: Correlation with Behcet\u2019s disease duration, activity and severity. Eur. J. Int. Med. 19, 541\u2013547. https:\/\/doi.org\/10.1016\/j.ejim.2008.08.001 (2008).","journal-title":"Eur. J. Int. Med."},{"issue":"Pt 5","key":"87130_CR56","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1042\/BST0351175","volume":"35","author":"EP Wijekoon","year":"2007","unstructured":"Wijekoon, E. P., Brosnan, M. E. & Brosnan, J. T. Homocysteine metabolism in diabetes. Biochem. Soc. Trans. 35(Pt 5), 1175\u20131179 (2007).","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"87130_CR57","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/biof.17","volume":"35","author":"J Zhou","year":"2009","unstructured":"Zhou, J. & Austin, R. C. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. Biofactors 35(2), 120\u2013129 (2009).","journal-title":"Biofactors"},{"key":"87130_CR58","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1515\/CCLM.2003.177","volume":"41","author":"L Piconi","year":"2003","unstructured":"Piconi, L., Quagliaro, L. & Ceriello, A. Oxidative stress in diabetes. Clin. Chem. Lab. Med. 41, 1144\u20131149. https:\/\/doi.org\/10.1515\/CCLM.2003.177 (2003).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"8","key":"87130_CR59","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ejim.2014.09.007","volume":"25","author":"NV Leach","year":"2014","unstructured":"Leach, N. V. et al. Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. Eur. J. Intern. Med. 25(8), 762\u2013767 (2014).","journal-title":"Eur. J. Intern. Med."},{"key":"87130_CR60","doi-asserted-by":"publisher","unstructured":"Kaplan, P., Tatarkova, Z., Sivonova, M. K., Racay, P. & Lehotsky, J. Homocysteine and mitochondria in cardiovascular and cerebrovascular systems. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21207698 (2020).","DOI":"10.3390\/ijms21207698"},{"key":"87130_CR61","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tips.2017.04.005","volume":"38","author":"P Poprac","year":"2017","unstructured":"Poprac, P. et al. Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol. Sci. 38, 592\u2013607. https:\/\/doi.org\/10.1016\/j.tips.2017.04.005 (2017).","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87130-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T01:34:15Z","timestamp":1737509655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87130-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87130"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87130-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors give consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"2746"}}